Hidradenitis suppurativa in sexual and gender minorities: A review and considerations for providers

Abstract

The literature on hidradenitis suppurativa in sexual and gender minorities remains sparse. This review article aims to discuss critical factors for providers to consider in lesbian, gay, bisexual, transgender, queer, intersex, and asexual patients with hidradenitis suppurativa, including associated comorbidities, gender-affirming hormonal therapy, squamous cell carcinoma, infections in HIV-positive patients, and creating a welcoming clinic for sexual and gender minority patients.

Keywords: HIV/AIDS; LGBTQIA health; gender identity; hidradenitis suppurativa; inflammation/inflammatory; medical dermatology; sexual and gender minorities; sexuality; squamous cell carcinoma.